[The problem of preclinical evaluation of psychotropic drugs].
D000293:Adolescent; D000328:Adult; D003863:Depression / Q000188:drug therapy; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D008875:Middle Aged; D009440:Neurasthenia / Q000188:drug therapy; D009497:Neurotic Disorders / Q000188:drug therapy; D010879:Piperazines / Q000627:therapeutic use; D011728:Pyridones / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy; D014230:Triazoles / Q000627:therapeutic use
D006993:Hypnotics and Sedatives; D010879:Piperazines; D011728:Pyridones; D014230:Triazoles
Il problema della valutazione pre-clinica dei nuovi farmaci psicotropi.